Interleukin23 in Systemic Lupus

计划入组 90 人 · 首次发布于 2024 年 12 月 3 日

Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety

计划入组 200 人 · 首次发布于 2025 年 10 月 14 日

Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)

计划入组 20 人 · 首次发布于 2025 年 1 月 24 日

Interleukin-1 alpha (Dainippon)

Interleukin-1 alpha (Roche)

Interleukin-1-alpha (Otsuka)

Alpha Metallurgical

United States

Zeno Alpha, Inc.

United States

Alpha Republic GmbH

Austria

Celltrion's Ustekinumab Biosimilar (CTP-43) Enters Pre-Registration for Psoriatic Arthritis

FDA Approves Additional Presentation for Alvotech and Teva's Ustekinumab Biosimilar

Tocilizumab Investigated for Acute Myocardial Infarction with Cardiogenic Shock